Month: May 2022

Alliance Trust PLC – Transacation in Own Shares

Written by Customer Service on May 10, 2022. Posted in Public Companies.

10 May 2022 Alliance Trust PLC TRANSACTION IN OWN SHARES The Board of Alliance Trust PLC (“the Company”) announces that on 9 May 2022 the Company purchased for cancellation 150,000 ordinary shares of 2.5p each at a price of 927.7119p per share. Therefore, the total number of voting rights in the Company is now 299,399,181. The above figure (299,399,181) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules. Enquiries: Alliance Trust PLC Telephone: 01382 938320

Fingerprints announces that Feitian has selected Fingerprints’ next-generation T-Shape™ (T2) solution for their biometric cards

Written by Customer Service on May 10, 2022. Posted in Public Companies.

World-leading biometrics company, Fingerprint Cards AB (Fingerprints™) and Feitian, a global leading provider of cyber security products and solutions, are happy to announce that they are continuing their long-lasting relationship by bringing to market biometric cards based on Fingerprints’ next generation T-Shape™ (T2) module and BEP-software platform, aimed at the payment and access segments. The T2 solution has ultra-low power consumption, and its robust biometric performance was recently demonstrated by achieving compliance with Mastercard’s new Fingerprint Sensor Evaluation Process. This new solution is even simpler to integrate into the standard automated card manufacturing process, using the proven and accepted T-Shape packaging delivered in dual row. For card manufacturers, this means higher throughput, reduced waste and...

Ultimovacs Announces Presentation of UV1 Immune Monitoring Data at Cancer Immunotherapy Annual Meeting

Written by Customer Service on May 10, 2022. Posted in Public Companies.

UV1 immune monitoring data from three Phase I/IIa clinical trials show dynamic T cell responses lasting up to 7.5 years Measurable UV1-specific immune response in 91% of patients when combined with checkpoint inhibitor, as compared to 82% and 67% without checkpoint inhibitor Immune responses induced more rapidly when UV1 was combined with a checkpoint inhibitor Development of UV1-specific immune responses associated with longer survival timeOslo, 10 May 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced the presentation of results from long-term follow-up data from three Phase I/IIa clinical. The data is substantiating the clinical relevancy of the UV1-specific immune response and the rationale for combining the Company’s lead product, the universal...

Immunicum AB: Immunicum AB (publ) Interim Report January – March 2022

Written by Customer Service on May 10, 2022. Posted in Earnings Releases And Operating Results.

JANUARY – MARCH IN SUMMARYNet sales for the period amounted to KSEK 1,794 (–). Result for the period amounted to KSEK -27,582 (-41,571). Earnings and diluted earnings per share totaled SEK -0.14 (-0.25). Immunicum transfers patent rights for modified adenovirus to Elicera Therapeutics Immunicum provided a pipeline and strategy outlook. In 2022, the clinical development focus will be on i) the continuation and further clinical data updates of the ADVANCE II study evaluating DCP-001 in the acute myeloid leukemia (AML) maintenance setting, ii) the continuation of the ALISON study in ovarian cancer, which will deliver a first clinical read-out in 2022 and iii) the evaluation and preparation of the TROY study, which will evaluate Ilixadencel’s potential in gastrointestinal stromal tumors (GIST) Immunicum has made further progress in...

CBI : Preliminary earnings for FY 2021-22

Written by Customer Service on May 10, 2022. Posted in Earnings Releases And Operating Results.

CBI : Preliminary earnings for FY 2021-222021-2022 preliminary consolidated revenues of €4.3 million for around four months of full activity from December 2021 2021-2022 preliminary consolidated EBIT of €1.9 million (45% of revenues) and preliminary consolidated net profit of €3.8 million (89% of revenues) Targeting significant business growth in 2022–23 with the opening of the metaverse and a number of universesCRYPTO BLOCKCHAIN INDUSTRIES (« CBI », Euronext Growth Paris : FR00140062P9 – ALCBI) is reporting its preliminary consolidated full-year earnings for FY 2021-22. The 12-month financial year ended on March 31, 2022 and the financial results under audit were reviewed by the Board of Directors on May 9, 2022. The audit procedures for the consolidated financial statements are currently being finalized. The auditors’...

The sales of „Vilvi Group“ April 2022

Written by Customer Service on May 10, 2022. Posted in Public Companies.

AB “Vilvi Group”, which consists of Vilkyškių pieninė AB, “Modest” AB, Kelmės pieninė AB, “Kelmės pienas” UAB, “Pieno logistika” AB and “Baltic Dairy Board” SIA, consolidated sales for April 2022 amounted to 19.51 million EUR – 60.1% increase comparing to April 2021. The sales of the Group for period January – April 2022 amounted to 69.96 million EUR – 59.5% increase comparing to the same period last year. Vilija Milaseviciute Economics and finance directorPhone: +370 441 55 102

Proactive news headlines including Alligator Energy, Aurumin Ltd, BlackEarth Minerals and Creso Pharma

Written by Customer Service on May 10, 2022. Posted in Mergers And Acquisitions.

Sydney, May 10, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Alligator Energy Ltd (ASX:AGE) has delivered high-grade intersections from sonic core drilling at Blackbush Deposit within the Samphire Uranium Project in South Australia. Click here Aurumin Ltd (ASX:AUN) has completed an orientation drill program targeting lithium-bearing pegmatites and has received all ultrafine soil sampling results from the Mt Palmer Lithium Project in Western Australia. Click here BlackEarth Minerals NL (ASX:BEM) has fielded more “outstanding” results from a 1,670-metre diamond drill program at the high-grade Razafy Northwest target, which forms part of the Maniry Graphite Project in Southern Madagascar. Click here Creso Pharma Ltd...

Hexagon Purus ASA: Results for the first quarter 2022

Written by Customer Service on May 10, 2022. Posted in Earnings Releases And Operating Results.

Hexagon Purus delivered robust year-over-year revenue growth in Q1 2022 coupled with strong commercial momentum across the business. Q1 2022 highlights:Revenue grew 209% year-over-year to NOK 159 million, including NOK 107 million contribution from Wystrach. Organic revenue on a standalone basis (i.e., as if Wystrach were an external customer in Q1 2022) was NOK 84 million, representing organic year-over-year growth of approximately 63% Signed a long-term binding letter of intent with Hino Motors Manufacturing U.S. and nominated by another leading, established commercial truck OEM to provide battery systems for serial production planned from 2024 Signed investment agreements together with JV partner CIMC Enric for construction of a joint production facility in Shijiazhuang and New Energy R&D management center in Beijing Daxing...

Eezy Plc’s Interim Report 1-3/2022: Strong growth continued

Written by Customer Service on May 10, 2022. Posted in Earnings Releases And Operating Results.

EEZY PLC — INTERIM REPORT — 10 MAY 2022 AT 8:00 Eezy Plc‘s Interim Report 1–3/2022: Strong growth continued January–March 2022Revenue was EUR 50.9 million (EUR 36.6 million in January–March 2021). EBITDA was EUR 2.5 million (2.8). EBIT was EUR 0.5 million (0.9) and was 1.0% of revenue (2.5 %). Earnings per share was EUR 0.00 (0.01). Revenue grew by 39% exceeding the market growth. Business continued to normalize from Corona conditions, but sick-leaves grew.Outlook for 2022 Eezy expects revenue to grow and EBIT-% to increase during 2022. The guidance will be made more precise during the year. Key figures (IFRS)EUR million, unlessotherwise specified 1–3/2022 1–3/2021 1–12/2021Revenue 50.9 36.6 203.3EBITDA 2.5 2.8 19.5EBITDA, % 4.9% 7.5% 9.6%EBIT 0.5 0.9 11.8EBIT, % 1.0% 2.5% 5.8%EPS,...

NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2022: Restaurant demand recovery faster than expected – the company expects its turnover to increase to approximately MEUR 300 already this year

Written by Customer Service on May 10, 2022. Posted in Earnings Releases And Operating Results.

NoHo Partners Plc INTERIM REPORT 10 May 2022 at 8:15 a.m. NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2022 Restaurant demand recovery faster than expected – the company expects its turnover to increase to approximately MEUR 300 already this year JANUARY–MARCH 2022 IN BRIEF Entire GroupTurnover increased by 140.6% to MEUR 48.5 (MEUR 20.2). EBIT increased by 86.6% to MEUR -1.3 (MEUR -9.7). The EBIT percentage was -2.7% (-48.3%). The result for the financial period was MEUR -3.6 (MEUR -10.8), an increase of 66.9%. Earnings per share were EUR -0.18 (EUR -0.49), an increase of 63.4%. The operational EBITDA* increased by 116.0% to MEUR 1.1 (MEUR -6.7). Finnish operationsTurnover increased by 86.2% to MEUR 37.3 (MEUR 20.1). EBIT increased by 69.1% to MEUR -2.4 (MEUR -7.6). The EBIT percentage was -6.3% (-38.1%). Operational...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals